Page last updated: 2024-10-28

gyki 52466 and Brain Neoplasms

gyki 52466 has been researched along with Brain Neoplasms in 2 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walczak, K1
Deneka-Hannemann, S1
Jarosz, B1
Zgrajka, W1
Stoma, F1
Trojanowski, T1
Turski, WA1
Rzeski, W1
Eyüpoglu, IY1
Hahnen, E1
Heckel, A1
Siebzehnrübl, FA1
Buslei, R1
Fahlbusch, R1
Blümcke, I1

Other Studies

2 other studies available for gyki 52466 and Brain Neoplasms

ArticleYear
Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:1

    Topics: Adult; Aged; Benzodiazepines; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation;

2014
Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. Technical note.
    Journal of neurosurgery, 2005, Volume: 102, Issue:4

    Topics: Animals; Benzodiazepines; Brain Neoplasms; Cell Death; Cell Movement; Cell Proliferation; Dentate Gy

2005